Aurora Mobile Limited Announces Second Quarter 2024 Unaudited Financial Results
SHENZHEN, China, Aug. 29, 2024 (GLOBE NEWSWIRE) — Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading […]
Galantas Report Financial Results for the Quarter Ended June 30, 2024
TORONTO, Aug. 29, 2024 (GLOBE NEWSWIRE) — Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) […]
Viridien wins contract to supply 30,000 Sercel WiNG land nodes to DMT
Viridien wins contract to supply 30,000 Sercel WiNG land nodes to DMT Paris, France – August 29, 2024 Viridien announced […]
Viridien remporte un contrat pour la fourniture de 30 000 nodes WiNG de la marque Sercel à DMT
Viridien remporte un contrat pour la fourniture de 30 000 nodes WiNG de la marque Sercel à DMT Paris, France – […]
WISeKey Subsidiary WISe.ART Presents NFTs from The Three Gates of Wisdom
Imagery from the award-winning AI film now available on the WISe.ART Platform Geneva, Switzerland – August 29, 2024: WISeKey […]
Perception Capital Corp. III received written notice from Nasdaq related to delayed filing of quarterly report on Form 10-Q
MINNEAPOLIS, Aug. 28, 2024 (GLOBE NEWSWIRE) — Perception Capital Corp. III (Nasdaq: PFTA) (the “Company”), a special purpose acquisition company, […]
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market
ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and […]
Independent Research Demonstrates ShotSpotter’s Impact, Effectiveness, Success and Value in Winston-Salem
Summary: SoundThinking, Inc. today announced recently published independent research that demonstrates benefits of ShotSpotter in Winston-Salem, including lives saved, reduction […]
NuLegacy Gold Closes 1st Tranche of Private Placement
By regulatory requirement,THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES […]
Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]
